Evidence map›Paper›PMID 33753407›Full record

ReviewThe British journal of ophthalmology2022

New digital models of care in ophthalmology, during and beyond the COVID-19 pandemic.

Yih-Chung Tham, Rahat Husain, Kelvin Yi Chong Teo, Anna Cheng Sim Tan, Annabel Chee Yen Chew, Daniel S Ting, Ching-Yu Cheng, Gavin Siew Wei Tan, Tien Yin Wong

Abstract readReview
In one paragraph

Review in The British journal of ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Nonadherence to anti-VEGF intravitreal injections in patients with diabetic macular edema : The names of the authors.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Observational
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. How glaucoma care changed for the better after the pandemic.Current opinion in ophthalmology · 2022
    Review
  17. Article
  18. Article
  19. The barriers to global eye care equity and the role of digital innovations.Advances in ophthalmology practice and research · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yih-Chung Tham *Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.ORCID 0000-0002-6752-797X
Rahat Husain *Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.
Kelvin Yi Chong TeoSingapore Eye Research Institute, Singapore National Eye Centre, Singapore.
Anna Cheng Sim TanSingapore Eye Research Institute, Singapore National Eye Centre, Singapore.
Annabel Chee Yen ChewSingapore Eye Research Institute, Singapore National Eye Centre, Singapore.
Daniel S TingSingapore Eye Research Institute, Singapore National Eye Centre, Singapore.ORCID 0000-0003-2264-7174
Ching-Yu ChengSingapore Eye Research Institute, Singapore National Eye Centre, Singapore.ORCID 0000-0002-4916-6074
Gavin Siew Wei Tan *Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.
Tien Yin Wong *Singapore Eye Research Institute, Singapore National Eye Centre, Singapore wong.tien.yin@singhealth.com.sg.ORCID 0000-0002-8448-1264

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 has led to massive disruptions in societal, economic and healthcare systems globally. While COVID-19 has sparked a surge and expansion of new digital business models in different industries, healthcare has been slower to adapt to digital solutions. The majority of ophthalmology clinical practices are still operating through a traditional model of 'brick-and-mortar' facilities and 'face-to-face' patient-physician interaction. In the current climate of COVID-19, there is a need to fuel implementation of digital health models for ophthalmology. In this article, we highlight the current limitations in traditional clinical models as we confront COVID-19, review the current lack of digital initiatives in ophthalmology sphere despite the presence of COVID-19, propose new digital models of care for ophthalmology and discuss potential barriers that need to be considered for sustainable transformation to take place.

Indexed as

COVID-19OphthalmologyTelemedicineHumansPandemicsSARS-CoV-2Covid-19diagnostic tests/investigationpublic healthtelemedicinevision

Identifiers

PMID33753407
PMCPMC8961770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.